共 69 条
[11]
Arnold DL(2006)Phenotype and prognosis in African-Americans with multiple sclerosis: a retrospective chart review Mult Scler 12 775-781
[12]
Bar-Or A(2006)Does multiple sclerosis-associated disability differ between races? Neurology 66 1235-1240
[13]
Gold R(2005)Response to interferon beta-1a treatment in African American multiple sclerosis patients Arch Neurol 62 1681-1683
[14]
Kappos L(2009)Modification of multiple sclerosis phenotypes by African ancestry at HLA Arch Neurol 66 226-233
[15]
Arnold DL(2012)Response to disease modifying therapies in African Americans with multiple sclerosis Ethn Dis 22 221-225
[16]
Fox RJ(2019)Plegridy observational program third interim analysis: safety and effectiveness of peginterferon beta-1a in a subgroup of African American patients Int J MS Care 21 45-468
[17]
Gold R(2011)Efficacy of natalizumab therapy in patients of African descent with relapsing multiple sclerosis: analysis of AFFIRM and SENTINEL data Arch Neurol 68 464-115
[18]
Phillips JT(2018)Adherence, persistence, and discontinuation among Hispanic and African American patients with multiple sclerosis treated with fingolimod or glatiramer acetate Curr Med Res Opin 34 107-undefined
[19]
Okwuokenye M(undefined)undefined undefined undefined undefined-undefined
[20]
Zhang A(undefined)undefined undefined undefined undefined-undefined